Warby Parker (WRBY) Cash from Financing Activities (2020 - 2026)
Warby Parker (WRBY) reported Cash from Financing Activities of -$6.2 million for Q1 2026, down 167.59% on a YoY basis from $9.1 million in Q1 2025, and down 166.21% quarter-over-quarter from -$2.3 million in Q4 2025.
Warby Parker (WRBY) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Warby Parker has reported Cash from Financing Activities for 7 years, with the latest figure at -$6.2 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 167.59% year-over-year to -$6.2 million; the trailing twelve-month figure through Mar 2026 stood at -$15.9 million (down 717.89% YoY), and the FY2025 full-year result was -$12.0 million, down 341.92% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$6.2 million, down from -$2.3 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $3.6 million in Q2 2024, with the low at -$6.2 million in Q1 2026.
- Historically, Cash from Financing Activities has averaged -$413882.4 across 5 years, with a median of $112000.0 in 2022.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities jumped 108.45% — and 2025, when it slumped 9904.26%.
- Warby Parker's Cash from Financing Activities stood at $1.2 million in 2022, then plunged by 39.01% to $730000.0 in 2023, then soared by 65.07% to $1.2 million in 2024, then slumped by 292.03% to -$2.3 million in 2025, then tumbled by 166.21% to -$6.2 million in 2026.
- The last three Cash from Financing Activities figures came in at -$6.2 million (Q1 2026), -$2.3 million (Q4 2025), and -$4.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Warby Parker | 3.11 Bn | 2.82 Bn | 131.04 Mn | -6.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.16 Mn |
| Mar 31, 2026 | -6.16 Mn |
| Dec 31, 2025 | -2.31 Mn |
| Dec 31, 2025 | -2.31 Mn |
| Sep 30, 2025 | -4.61 Mn |
| Sep 30, 2025 | -4.61 Mn |
| Jun 30, 2025 | -2.77 Mn |
| Jun 30, 2025 | -2.77 Mn |
| Mar 31, 2025 | -2.30 Mn |
| Mar 31, 2025 | -2.30 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Sep 30, 2024 | 47,000.00 |
| Sep 30, 2024 | 47,000.00 |
| Jun 30, 2024 | 3.62 Mn |
| Jun 30, 2024 | 3.62 Mn |
| Mar 31, 2024 | 91,000.00 |
| Mar 31, 2024 | 91,000.00 |
| Dec 31, 2023 | 730,000.00 |
| Dec 31, 2023 | 730,000.00 |